The Pro-Neurotrophin Receptor Sortilin Is a Major Neuronal Apolipoprotein E Receptor for Catabolism of Amyloid-β Peptide in the Brain

被引:74
作者
Carlo, Anne-Sophie [1 ]
Gustafsen, Camilla [2 ]
Mastrobuoni, Guido [1 ]
Nielsen, Morten S. [2 ]
Burgert, Tilman [1 ]
Hartl, Daniela [3 ]
Rohe, Michael [1 ]
Nykjaer, Anders [2 ]
Herz, Joachim [4 ]
Heeren, Joerg [5 ]
Kempa, Stefan [1 ]
Petersen, Claus Munck [2 ]
Willnow, Thomas E. [1 ]
机构
[1] Max Delbrueck Ctr Mol Med, D-13125 Berlin, Germany
[2] Univ Aarhus, Dept Biomed, MIND Ctr, DK-8000 Aarhus, Denmark
[3] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany
[4] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[5] Univ Clin Hamburg Eppendorf, D-20246 Hamburg, Germany
关键词
DENSITY-LIPOPROTEIN RECEPTOR; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; A-BETA; MOUSE MODEL; INTRACELLULAR DOMAIN; CEREBROSPINAL-FLUID; TRANSGENIC MICE; TYPE-4; ALLELE;
D O I
10.1523/JNEUROSCI.2425-12.2013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Apolipoprotein E (APOE) is the major risk factor for sporadic Alzheimer's disease. Among other functions, APOE is proposed to sequester neurotoxic amyloid-beta (A beta) peptides in the brain, delivering them to cellular catabolism via neuronal APOE receptors. Still, the receptors involved in this process remain controversial. Here, we identified the pro-neurotrophin receptor sortilin as major endocytic pathway for clearance of APOE/A beta complexes in neurons. Sortilin binds APOE with high affinity. Lack of receptor expression in mice results in accumulation of APOE and of A beta in the brain and in aggravated plaque burden. Also, primary neurons lacking sortilin exhibit significantly impaired uptake of APOE/A beta complexes despite proper expression of other APOE receptors. Despite higher than normal brain APOE levels, sortilin-deficient animals display anomalies in brain lipid metabolism (e.g., accumulation of sulfatides) seen in APOE-deficient mice, indicating functional deficiency in cellular APOE uptake pathways. Together, our findings identified sortilin as an essential neuronal pathway for APOE-containing lipoproteins in vivo and suggest an intriguing link between A beta catabolism and pro-neurotrophin signaling converging on this receptor.
引用
收藏
页码:358 / 370
页数:13
相关论文
共 62 条
[11]   Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo [J].
Farris, W ;
Mansourian, S ;
Chang, Y ;
Lindsley, L ;
Eckman, EA ;
Frosch, MP ;
Eckman, CB ;
Tanzi, RE ;
Selkoe, DJ ;
Guénette, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :4162-4167
[12]   BACE1 Retrograde Trafficking Is Uniquely Regulated by the Cytoplasmic Domain of Sortilin [J].
Finan, Gina M. ;
Okada, Hirokazu ;
Kim, Tae-Wan .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (14) :12602-12616
[13]   The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice [J].
Fryer, JD ;
DeMattos, RB ;
McCormick, LM ;
O'Dell, MA ;
Spinner, ML ;
Bales, KR ;
Paul, SM ;
Sullivan, PM ;
Parsadanian, M ;
Bu, GJ ;
Holtzman, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (27) :25754-25759
[14]   ALZHEIMER-TYPE NEUROPATHOLOGY IN TRANSGENIC MICE OVEREXPRESSING V717F BETA-AMYLOID PRECURSOR PROTEIN [J].
GAMES, D ;
ADAMS, D ;
ALESSANDRINI, R ;
BARBOUR, R ;
BERTHELETTE, P ;
BLACKWELL, C ;
CARR, T ;
CLEMENS, J ;
DONALDSON, T ;
GILLESPIE, F ;
GUIDO, T ;
HAGOPIAN, S ;
JOHNSONWOOD, K ;
KHAN, K ;
LEE, M ;
LEIBOWITZ, P ;
LIEBERBURG, I ;
LITTLE, S ;
MASLIAH, E ;
MCCONLOGUE, L ;
MONTOYAZAVALA, M ;
MUCKE, L ;
PAGANINI, L ;
PENNIMAN, E ;
POWER, M ;
SCHENK, D ;
SEUBERT, P ;
SNYDER, B ;
SORIANO, F ;
TAN, H ;
VITALE, J ;
WADSWORTH, S ;
WOLOZIN, B ;
ZHAO, J .
NATURE, 1995, 373 (6514) :523-527
[15]   Novel role for apolipoprotein E in the central nervous system - Modulation of sulfatide content [J].
Han, XL ;
Cheng, H ;
Fryer, JD ;
Fagan, AM ;
Holtzman, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (10) :8043-8051
[16]   Astroglial regulation of apolipoprotein E expression in neuronal cells - Implications for Alzheimer's disease [J].
Harris, FM ;
Tesseur, I ;
Brecht, WJ ;
Xu, Q ;
Mullendorff, K ;
Chang, SJ ;
Wyss-Coray, T ;
Mahley, RW ;
Huang, YD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (05) :3862-3868
[17]  
Heeren J, 1999, J CELL SCI, V112, P349
[18]   Measurement of apolipoprotein E (apoE) in cerebrospinal fluid [J].
Hesse, C ;
Larsson, H ;
Fredman, P ;
Minthon, L ;
Andreason, N ;
Davidsson, P ;
Blennow, K .
NEUROCHEMICAL RESEARCH, 2000, 25 (04) :511-517
[19]   Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease [J].
Holtzman, David M. ;
Herz, Joachim ;
Bu, Guojun .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (03)
[20]   Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease [J].
Holtzman, DM ;
Bales, KR ;
Wu, S ;
Bhat, P ;
Parsadanian, M ;
Fagan, AM ;
Chang, LK ;
Sun, YL ;
Paul, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) :R15-R21